Literature DB >> 15447771

Dietary fructose and gastrointestinal symptoms: a review.

Suzanne M Skoog1, Adil E Bharucha.   

Abstract

It has been proposed that fructose may cause or aggravate symptoms in patients with functional gastrointestinal disorders. Fructose is commonly used to sweeten processed foods, and the prevalence of incomplete fructose absorption (25 g, 10%) in healthy subjects is as high as 50%. The only controlled study that has been performed did not demonstrate a higher prevalence of fructose-induced gastrointestinal symptoms or incomplete fructose absorption in patients with functional gastrointestinal disorders. The amount and concentration of fructose used to evaluate absorption by breath testing has varied among studies. Moreover, dietary sources of fructose usually contain glucose, which increases fructose absorption in healthy subjects. Thus, breath testing with fructose alone may not reflect fructose ingestion under normal circumstances. Given these limitations, we suggest that a practical, empirical approach to testing in patients with suspected incomplete fructose absorption is to restrict fructose ingestion. Additional controlled studies are needed to clarify the relation between incomplete fructose absorption and symptoms, assess the effects of co-ingestion of other sugars on fructose absorption, and evaluate the effects of eliminating sugars from the diet on gastrointestinal symptoms.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15447771     DOI: 10.1111/j.1572-0241.2004.40266.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  26 in total

1.  Management of fecal incontinence.

Authors:  Adil E Bharucha
Journal:  Gastroenterol Hepatol (N Y)       Date:  2008-11

2.  Prevalence and risk factors for abdominal bloating and visible distention: a population-based study.

Authors:  X Jiang; G R Locke; R S Choung; A R Zinsmeister; C D Schleck; N J Talley
Journal:  Gut       Date:  2008-06       Impact factor: 23.059

Review 3.  Glucose transporters in the small intestine in health and disease.

Authors:  Hermann Koepsell
Journal:  Pflugers Arch       Date:  2020-08-23       Impact factor: 3.657

4.  The prevalence of celiac disease among patients with nonconstipated irritable bowel syndrome is similar to controls.

Authors:  Brooks D Cash; Joel H Rubenstein; Patrick E Young; Andrew Gentry; Borko Nojkov; Dong Lee; A Hirsohi Andrews; Richard Dobhan; William D Chey
Journal:  Gastroenterology       Date:  2011-07-14       Impact factor: 22.682

Review 5.  Fructose and cardiometabolic disorders: the controversy will, and must, continue.

Authors:  Nicolas Wiernsperger; Alain Geloen; Jean-Robert Rapin
Journal:  Clinics (Sao Paulo)       Date:  2010-07       Impact factor: 2.365

Review 6.  Heterogeneous effects of fructose on blood lipids in individuals with type 2 diabetes: systematic review and meta-analysis of experimental trials in humans.

Authors:  John L Sievenpiper; Amanda J Carleton; Sheena Chatha; Henry Y Jiang; Russell J de Souza; Joseph Beyene; Cyril W C Kendall; David J A Jenkins
Journal:  Diabetes Care       Date:  2009-07-10       Impact factor: 17.152

Review 7.  Fructose metabolism and metabolic disease.

Authors:  Sarah A Hannou; Danielle E Haslam; Nicola M McKeown; Mark A Herman
Journal:  J Clin Invest       Date:  2018-02-01       Impact factor: 14.808

8.  Fructose-induced symptoms beyond malabsorption in FGID.

Authors:  Jessica R Biesiekierski
Journal:  United European Gastroenterol J       Date:  2014-02       Impact factor: 4.623

Review 9.  Use and abuse of hydrogen breath tests.

Authors:  M Simrén; P-O Stotzer
Journal:  Gut       Date:  2006-03       Impact factor: 23.059

10.  Ability of the normal human small intestine to absorb fructose: evaluation by breath testing.

Authors:  Satish S C Rao; Ashok Attaluri; Leslie Anderson; Phyllis Stumbo
Journal:  Clin Gastroenterol Hepatol       Date:  2007-07-10       Impact factor: 11.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.